RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6

      한글로보기

      https://www.riss.kr/link?id=A101635581

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Dysregulated microRNA (miRNA) expression has a critical role in tumor development and metastasis. However, the mechanism by which miRNAs control melanoma metastasis is unknown. Here, we report reduced miR-98 expression in melanoma tissues with increas...

      Dysregulated microRNA (miRNA) expression has a critical role in tumor development and metastasis. However, the mechanism by which miRNAs control melanoma metastasis is unknown. Here, we report reduced miR-98 expression in melanoma tissues with increasing tumor stage as well as metastasis; its expression is also negatively associated with melanoma patient survival. Furthermore, we demonstrate that miR-98 inhibits melanoma cell migration in vitro as well as metastatic tumor size in vivo. We also found that IL-6 is a target gene of miR-98, and IL-6 represses miR-98 levels via the Stat3-NF-κB-lin28B pathway. In an in vivo melanoma model, we demonstrate that miR-98 reduces melanoma metastasis and increases survival in part by reducing IL-6 levels; it also decreases Stat3 and p65 phosphorylation as well as lin28B mRNA levels. These results suggest that miR-98 inhibits melanoma metastasis in part through a novel miR-98-IL-6-negative feedback loop.

      더보기

      참고문헌 (Reference)

      1 Zhang S, "miR-98 regulates cisplatininduced A549 cell death by inhibiting TP53 pathway" 65 : 436-442, 2011

      2 Baade P, "Trends in melanoma mortality in Australia : 1950–2002and their implications for melanoma control" 29 : 383-386, 2005

      3 Coory M, "Trends for in situ and invasive melanoma in Queensland, Australia, 1982–2002" 17 : 21-27, 2006

      4 Naugler WE, "The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer" 14 : 109-119, 2008

      5 Jostock T, "Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses" 268 : 160-167, 2001

      6 Hoejberg L, "Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma" 22 : 287-293, 2012

      7 Bar-Eli M, "Searching for the ‘melano-miRs’ : miR-214 drives melanoma metastasis" 30 : 1880-1881, 2011

      8 Mueller DW, "Role of miRNAs in the progression of malignant melanoma" 101 : 551-556, 2009

      9 Schuchter LM, "Review of the 2001 AJCC staging system for cutaneous malignant melanoma" 3 : 332-337, 2001

      10 Karst AM, "Nuclear factor kappa B subunit p50promotes melanoma angiogeensis by upregulating interleukin 6 expression" 124 : 494-507, 2009

      1 Zhang S, "miR-98 regulates cisplatininduced A549 cell death by inhibiting TP53 pathway" 65 : 436-442, 2011

      2 Baade P, "Trends in melanoma mortality in Australia : 1950–2002and their implications for melanoma control" 29 : 383-386, 2005

      3 Coory M, "Trends for in situ and invasive melanoma in Queensland, Australia, 1982–2002" 17 : 21-27, 2006

      4 Naugler WE, "The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer" 14 : 109-119, 2008

      5 Jostock T, "Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses" 268 : 160-167, 2001

      6 Hoejberg L, "Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma" 22 : 287-293, 2012

      7 Bar-Eli M, "Searching for the ‘melano-miRs’ : miR-214 drives melanoma metastasis" 30 : 1880-1881, 2011

      8 Mueller DW, "Role of miRNAs in the progression of malignant melanoma" 101 : 551-556, 2009

      9 Schuchter LM, "Review of the 2001 AJCC staging system for cutaneous malignant melanoma" 3 : 332-337, 2001

      10 Karst AM, "Nuclear factor kappa B subunit p50promotes melanoma angiogeensis by upregulating interleukin 6 expression" 124 : 494-507, 2009

      11 Zhang L, "MicroRNAs exhibit high frequency genomic alterations in human cancer" 103 : 9136-9141, 2006

      12 Xiang Q, "MicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2" 68 : 274-281, 2013

      13 Huang SD, "MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma" 11 : 51-, 2012

      14 Bemis LT, "MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines" 68 : 1362-1368, 2008

      15 Siragam V, "MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11" 3 : 1370-1385, 2012

      16 Schultz J, "MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth" 18 : 549-557, 2008

      17 Howell PM, "MicroRNA in melanoma" 10 : 83-92, 2010

      18 Lu J, "MicroRNA expression profiles classify human cancers" 435 : 834-838, 2005

      19 Mueller DW, "MiRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma" 129 : 1740-1751, 2009

      20 Tucker MA, "Melanoma epidemiology" 23 : 383-395, 2009

      21 Fu TY, "Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells" 317 : 445-451, 2011

      22 Hoejberg L, "Interleukin-6 and melanoma" 22 : 327-333, 2012

      23 Terai M, "Interleukin 6 mediates production of interleukin 10 in metastatic melanoma" 61 : 145-155, 2012

      24 Linos E, "Increasing burden of melanoma in the United States" 129 : 1666-1674, 2009

      25 Ting HJ, "Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D" 288 : 1-9, 2013

      26 Panda H, "Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3" 97 : E1316-E1326, 2012

      27 Jemal A, "Cancer statistics, 2008" 58 : 71-96, 2008

      28 Segura MF, "Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor" 106 : 1814-1819, 2009

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2009-09-21 학회명변경 한글명 : 대한생화학ㆍ분자생물학회 -> 생화학분자생물학회
      영문명 : Korean Society Of Medical Biochemistry And Molecular Biology -> Korean Society Of Biochemistry And Molecular Biology
      KCI등재
      2008-01-01 평가 SCI 등재 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 3.74 0.23 2.56
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.82 1.45 0.555 0.01
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼